Anything But Generic.

At Mylan, we work around the clock and around the globe to help provide 7 billion people access to medicine. We aim to produce high quality, more global map affordable pharmaceuticals to be made available everywhere, every day – no exceptions. Our global network of employees is obsessed with quality and dedicated to Innovation, Integrity, Reliability, Service and Teamwork.

Latest News

  • 2/02/2012 Mylan Receives Tentative FDA Approval for Generic Version of Lipitor®. More
  • 1/24/2012 Mylan to Host Investor Day on Feb. 21, 2012, in New York City. More
  • 1/19/2012 Mylan Launches Innovative Version of Antiepileptic Drug Levetiracetam. More
More News